Newsroom

Solenic news

Company milestones, regulatory progress, peer-reviewed research and press coverage.

Text size

35 items · 2026 to 2019

2026

Jun 23, 2026·Dallas, TX·GlobeNewswire

Solenic Medical® Receives FDA IDE Approval to Initiate Pivotal Trial of SOLA-2™ for Periprosthetic Joint Infections

Solenic Medical, a pioneering medical device company focused on developing a non-invasive treatment platform for advanced implant infection care, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Investigational Device Exemption (IDE) application, authorizing the launch of a pivotal clinical trial for its SOLA-2™ Alternating Magnetic Field (AMF) System in patients with periprosthetic joint infections (PJI).

GlobeNewswire

Feb 27, 2026·Dallas, TX·GlobeNewswire

Solenic Medical Announces Publication in Scientific Reports Demonstrating Enhanced Anti-Biofilm Activity Using Alternating Magnetic Fields

Solenic Medical today announced the publication of new peer-reviewed research in Scientific Reports, a journal from Nature Portfolio, demonstrating that alternating magnetic fields (AMF) significantly enhance antibiotic activity against bacterial biofilms across a broad range of pathogens and antibiotics, addressing a central challenge in the treatment of metallic implant-associated infections.

GlobeNewswire

2025

Oct 21, 2025·Dallas, TX·GlobeNewswire

Solenic Medical Announced the Successful, FDA-Authorized Compassionate Use of its Investigational Alternating Magnetic Field (AMF) Technology.

Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today announced the successful, FDA-authorized compassionate use of its investigational Alternating Magnetic Field (AMF) technology. The noninvasive AMF treatment was delivered as an adjunct to surgery in a patient with a serious medical condition involving a prosthetic joint infection (PJI).

GlobeNewswire

Jul 8, 2025·Addison, TX·Solenic Medical

Solenic Medical Appoints Medical Device Industry Veteran Bart Bandy as Chief Executive Officer

Solenic Medical, a leading innovator focused on revolutionizing orthopedic implant infection care, announced today the appointment of Bart Bandy as its new Chief Executive Officer. He brings more than 30 years of healthcare leadership experience, including a strong track record of driving growth and commercialization in both private and public medical technology companies.

Solenic Medical (PDF)

Apr 2, 2025·Addison, TX·VIC Technology

Solenic Medical Achieves Milestone: First Patient Successfully Treated in Early Feasibility Clinical Trial

Solenic Medical Inc., a pioneering medical device company focused on non-invasive solutions for infected metallic implants, today announced a significant achievement in its mission. The company has successfully treated its first patient as part of its early feasibility clinical trial utilizing its groundbreaking, investigational Alternating Magnetic Field (AMF) technology.

VIC Technology

Feb 6, 2025·Dallas, TX·VIC Technology

Solenic Medical Strengthens Advisory Boards with Key Appointments

Solenic Medical Inc., a pioneering company in non-invasive infection control for metallic implants, proudly announces the addition of three distinguished experts to its advisory boards. The expansion reflects Solenic Medical’s commitment to advancing medical innovation and strengthening its strategic growth initiatives.

VIC Technology

2024

Nov 8, 2024·Dallas, TX·Solenic Medical

Solenic Medical Wins 2024 AAHKS Industry Innovation Award

Solenic Medical Inc. won the Industry Innovation Award at the 2024 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS) held in Dallas TX, from November 8th to the 9th. Solenic Medical was recognized for it patented technology using alternating magnetic fields (AMF) to generate thermal medical on the surface of the implants, aiming to eradicate biofilms.

Solenic Medical (PDF)

Sep 27, 2024·Boston, MA·Solenic Medical

Solenic Medical selected by RESI judges as one of the top pitches during the Innovator’s Pitch Challenge in Boston.

Solenic Medical Inc. was selected as one of the highest scoring pitches at the Redefining Early Stage Investments (RESI) Boston event presented by Life Science Nation. 56 innovative companies were divided into 14 sessions, each with four unique startups organized by sector or technology. A panel of experienced judges selected top scoring pitches, like Solenic’s, based on their high-quality pitches, ability to address difficult topics, and clear communication of their value offer.

Solenic Medical (PDF)

Aug 31, 2024·Nashville, TN·Solenic Medical

Solenic Medical Wins Best Scientific Poster Award at ISTA Conference.

Solenic Medical Inc. won the Best Scientific Poster Award at the 35th International Society of Technology in Arthroplasty (ISTA) conference held in Nashville, TN from August 28th to 31st. The winning poster, titled “Safety, Efficacy, and Validation of AMF Heating on a Primary Knee Implant and Surrounding Tissues Using Human Cadaver and Digital Knee Models,” highlights Solenic’s commitment to advancing orthopedic technology. >>Learn More >>See Poster

Solenic Medical (PDF)

May 30, 2024·Los Angeles·MedTech Innovator

Solenic Medical Named to MedTech Innovator 2024 Cohort

MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced its 2024 Accelerator Cohort. After a competitive selection process with a five percent acceptance rate, 65 companies were chosen to participate in MTI’s flagship four-month Accelerator program.

MedTech Innovator

Jan 15, 2024·VIC Technology

Solenic Medical to Exhibit at the 2024 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in San Francisco

Solenic Medical Inc. will be a first time exhibitor (Booth #4142) at The American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting February 12-14th. This is the premier event in the field of orthopaedic surgery, bringing together professionals, researchers, and experts to exchange knowledge and advancements in musculoskeletal care.

VIC Technology

2023

Nov 9, 2023·VIC Technology

Solenic Medical Unveils the SOLA2 System at the Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS)

ADDISON, TEXAS- The Solenic team exhibited at the 2023 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS). AAHKS brings together experienced Hip and Knee replacement surgeons and their industry partners to discuss scientific topics such as implant design, outcomes, surgical techniques, and complications of primary and revision total joint arthroplasty.

VIC Technology

2022

May 13, 2022

Solenic Medical receives top votes from Shark Tank judges at Anterior Hip Foundation 2022 Innovation Symposium

At the event, which featured judges from the senior management of various leading orthopedic companies. Ten innovative orthopedics companies presented at the Shark Tank, and of them, Solenic Medical received top votes from the judges in attendance, while Esy Solution received top votes from the general audience.

2021

Mar 23, 2021·Dallas Business Journal

DFW Medical Device Startup Eyes New Funding as it Looks Toward Human Trials

What’s the commonality between VC funding and sheep? Both will help Solenic Medical on its path to treating prosthetic joint infection. The UT Southwestern-affiliated medical device startup, which has most of its workforce in DFW, is fresh off new raises and is looking to raise more as it gears up for renewed animal trials on its way to testing its tech in human patients. >>Full Article

Dallas Business Journal

2020

Jul 30, 2020·PRWeb

Solenic Medical, Inc. Receives FDA Breakthrough Device Designation for AMF Device

JULY 30, 2020- COLLEGE STATION, TEXAS- Solenic Medical, a developer of a device that uses alternating magnetic fields to treat a prosthetic joint infections (PJI) announced today that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA).Breakthrough Designation is reserved for devices or technologies that may provide for more effective treatment of life-threatening or irreversibly debilitating conditions in order to give patients timely access. >>Full Article

PRWeb

Jun 2, 2020·MassChallenge

MassChallenge Texas in Houston Announces Summer 2020 Cohort

MassChallenge, a global network of zero-equity startup accelerators, today announced the 56 early-stage startups invited to join the 2020 MassChallenge Texas in Houston program. These startups have been rigorously vetted by a community of more than 500 expert judges and represent the top 11% of applications from around the world; the selected startups more than double the number of startups accepted to the program’s 2019 bootcamp. >>Full Article

MassChallenge

Apr 16, 2020·Texas A&M

Texas A&M New Ventures Competition goes virtual: 16 semifinalists announced for May competition

April 16, 2020— The Texas A&M New Ventures Competition (TNVC) is hosting its annual competition completely online this year to protect competitors, judges and staff during the COVID-19 pandemic. Sixteen semifinalists and eight alternates for the 2020 competition will compete May 14 for hundreds of thousands in startup funds during online rounds of pitch competitions and judging. >>Full Article

Texas A&M

2019

Nov 7, 2019·J&J Innovation JLABS

NERv Medical, PATH EX, and Solenic Medical Named Awardees in JLABS @ TMC Breakthrough Medical Technologies QuickFire Challenge

HOUSTON, TX November 7, 2019— Johnson & Johnson Innovation, JLABS announced today at TMCx Demo Day 2019 that NERv Medical, PATH EX, and Solenic Medical have been selected as the award recipients in the JLABS @ TMC Breakthrough Medical Technologies QuickFire Challenge. The Challenge was designed to ignite innovation in health tech and provide the innovators with the best ideas resources to advance their science. The announcement was made by Allan Miranda, Head of JLABS Canada and Interim Head of JLABS @ TMC . >>Full Article

J&J Innovation JLABS

Jun 19, 2019·VIC Technology

VIC Technology Venture Development™ Forms New Portfolio Company, Solenic Medical, Inc.

DALLAS, June 19, 2019 — VIC Technology Venture Development, LLC (VIC) has announced that it has formed Solenic Medical, Inc. The company was established to develop and commercialize a method for treating prosthetic joint infection (PJI) based on technology exclusively licensed from University of Texas Southwestern Medical Center (UTSW). The patent-pending technology offers an approach for the eradication of biofilm from metallic implants. Advantages include non-invasive treatment of PJI through selective targeting of biofilms. >>Full Article

VIC Technology